Switch to:
Haemonetics Corporation (NYSE:HAE)
EV/EBIT
37.00 (As of Today)

EV/EBIT ratio is calculated as enterprise value divided by its EBIT. As of today, Haemonetics Corporation's enterprise value is $1,992.6 Mil. Haemonetics Corporation's operating income for the trailing twelve months (TTM) ended in Dec. 2013 was $52.4 Mil. Therefore, Haemonetics Corporation's EV/EBIT ratio for today is 37.00.

HAE' s 10-Year EV/EBIT Range
Min: 9.9   Max: 71.9
Current: 37

9.9
71.9

During the past 13 years, the highest EV/EBIT Ratio of Haemonetics Corporation was 71.90. The lowest was 9.90. And the median was 15.90.

HAE's EV/EBITis ranked lower than
66% of the 247 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 18.32 vs. HAE: 37.00 )

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt). Haemonetics Corporation's enterprise value for the quarter that ended in Dec. 2013 was $2,440.3 Mil. Haemonetics Corporation's Operating Income for the trailing twelve months (TTM) ended in Dec. 2013 was $52.4 Mil. Haemonetics Corporation's Earnings Yield (Joel Greenblatt) for the quarter that ended in Dec. 2013 was 2.15%.


Definition

Haemonetics Corporation's EV/EBIT for today is calculated as:

EV/EBIT=Enterprise Value (Today)/Operating Income (TTM)
=1992.610/52.39
=38.03

Haemonetics Corporation's current Enterprise Value is $1,992.6 Mil.
Haemonetics Corporation's Operating Income for the trailing twelve months (TTM) ended in Dec. 2013 was 17.708 (Mar. 2013 ) + -6.608 (Jun. 2013 ) + 23.43 (Sep. 2013 ) + 17.86 (Dec. 2013 ) = $52.4 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

This is a more accurate valuation of companies' operation because it consider the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt).

Haemonetics Corporation's Earnings Yield (Joel Greenblatt) for the quarter that ended in Dec. 2013 is calculated as:

Earnings Yield (Joel Greenblatt) (Q: Dec. 2013 )=Operating Income (TTM)/Enterprise Value (Q: Dec. 2013 )
=52.39/2440.3409
=2.15 %

Haemonetics Corporation's Enterprise Value for the quarter that ended in Dec. 2013 was $2,440.3 Mil.
Haemonetics Corporation's Operating Income for the trailing twelve months (TTM) ended in Dec. 2013 was 17.708 (Mar. 2013 ) + -6.608 (Jun. 2013 ) + 23.43 (Sep. 2013 ) + 17.86 (Dec. 2013 ) = $52.4 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Related Terms

Enterprise Value, Operating Income, Earnings Yield (Joel Greenblatt)


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Haemonetics Corporation Annual Data

Mar04Mar05Mar06Mar07Mar08Mar09Mar10Mar11Mar12Mar13
ev2ebit 15.3915.8711.6316.5420.0814.7316.0013.4817.3343.00

Haemonetics Corporation Quarterly Data

Sep11Dec11Mar12Jun12Sep12Dec12Mar13Jun13Sep13Dec13
ev2ebit 12.8513.8517.3321.3434.1240.1843.0066.3946.9546.58
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide